Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05343494 · ClinicalTrials.gov registry record · NA

Maternal Health Diabetes Prevention Study

A NA study of PreDiabetes and Gestational Diabetes, sponsored by Tulane University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05343494 is a NA study of PreDiabetes and Gestational Diabetes that has completed, run by Tulane University. The registered enrollment target is 20 participants, below the 691-participant average among 89 other PreDiabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05343494, a NA study of PreDiabetes and Gestational Diabetes, has completed, sponsored by Tulane University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The aim of this project is to use the Exploration, Preparation, Implementation, Sustainment (EPIS) framework to collect pilot data on the implementation of a Diabetes Prevention Program-like intervention in the Women, Infants, and Children (WIC) program.

Interventions

  • BEHAVIORAL Lifestyle Intervention

Study Locations (1)

Louisiana

  • Tulane Office of Health Research - New Orleans

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-04-04
Est. Completion 2022-10-05
Phase NA

Sponsor

Tulane University

73 total trials

What the Registry Record Tells You About NCT05343494

The ClinicalTrials.gov registry entry for NCT05343494 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 691-participant average among 89 other PreDiabetes trials with a reported enrollment target (97% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle Intervention is the first listed.

NCT05343494 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT05343494 about?

NCT05343494 is a clinical study titled "Maternal Health Diabetes Prevention Study". The aim of this project is to use the Exploration, Preparation, Implementation, Sustainment (EPIS) framework to collect pilot data on the implementation of a Diabetes Prevention Program-like intervention in the Women, Infants, and Children (WIC) program.

What is the current status of trial NCT05343494?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-04-04. Estimated completion is 2022-10-05.

What conditions does trial NCT05343494 study?

This clinical trial studies the following conditions: PreDiabetes, Gestational Diabetes, Hyperglycemia, Glucose Intolerance During Pregnancy.

What interventions are being tested in trial NCT05343494?

The interventions under investigation include: Lifestyle Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05343494?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05343494 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.